The results showed that CD8+ cell depletion facilitated tumor outgrowth in mice receiving i.t. rlipoE7m-MoGM therapy, whereas tumor regression was observed in mice treated with control rat IgG antibody. The gene discussed is CD8A; the disease is neoplasm.